Researchers collected skin, stool and oral samples from 115 ICU patients spread across four hospitals in the United States and Canada. They analyzed the samples’ bacterial populations at 48 hours after admission and after 10 days in the ICU or at discharge.
They then compared those results to samples from healthy people who participated in the American Gut project, a crowd-sourced project focused on characterizing the human microbiome.
Comparatively, ICU patients’ samples had lower levels of firmicutes and bacteroidetes bacteria and higher levels of proteobacteria, which can include pathogens.
“The results were what we feared them to be,” Paul Wischmeyer, MD, the study’s lead author. “We saw a massive depletion of normal, health-promoting species.”
What struck Dr. Wischmeyer and the team was the speed with which the patients’ microbiomes changed. “We saw the rapid rise of organisms clearly associated with disease…In some cases, those organisms became 95 percent of the entire gut flora — all made up of one pathogenic taxa — within days of admission to the ICU,” he said.
Tracking the microbiome along with other vital signs could be a useful tool to identify risks before patients become symptomatic, Dr. Wischmeyer said.
More articles on microbiomes:
2 Conn. firms partner to dissect C. diff genome
Common antimicrobial agent quickly disrupts gut microbiomes, study finds
Gut bacteria and cancer research: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
